PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1397138
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1397138
Disposable Endoscopes Market size was valued at USD 2,810.6 Million in 2022, expanding at a CAGR of 17.1% from 2023 to 2030.
Endoscopy serves the purposes of diagnosing, preventing, and treating issues within visceral organs. Disposable endoscopes are introduced into the body through incisions, particularly in arthroscopy, or via natural openings or cavities like the mouth and anus. To assist healthcare professionals, such as endoscopists, in examining the internal organs, disposable endoscopes are equipped with various components, including cameras and light sources at the tip.
The global market is being driven by the increasing demand for single-use endoscopes, primarily to reduce the risk of device-related infections. Additionally, patient preference for minimally invasive procedures, supportive regulatory frameworks, and favorable reimbursement policies in developed countries are further propelling market growth. Government investments, funding, and grants to enhance healthcare infrastructure and endoscopy research are creating lucrative opportunities. The growing adoption of minimally invasive procedures, driven by their benefits like high patient acceptance, reduced pain, cost-effectiveness, and fewer complications, is boosting market uptake. For example, data from the NIH as of January 2023 shows a rising trend in ambulatory minimally invasive procedures in the U.S. Furthermore, the increasing demand for disposable endoscopes in hospitals, diagnostic centers, and their use in ENT, bronchoscopy, and dentistry procedures is expected to drive future growth.
The Global Disposable Endoscopes Market is segmented on the basis of Type, Application, End Use, and Region.
The market is divided into fifteen categories based on type: Laparoscopes, Ureteroscopes, Cystoscopes, Arthroscopes, Neuroendoscopes, Bronchoscopes, Gynecology Endoscopes, Hysteroscopes, Otoscopes, Sigmoidoscopes, Laryngoscopes, Duodenoscopes, Nasopharyngoscopes, Rhinoscopes, and Colonoscopes. In 2022, the bronchoscopes segment secured the largest share of revenue and it is expected to maintain a steady growth trajectory in the foreseeable future. The substantial share of this segment can be attributed to the increasing incidence of respiratory and lung disorders and the widespread adoption of minimally invasive bronchoscopy procedures. According to the World Health Organization (WHO), COPD ranks as the third chief cause of global mortality, with around 90% of COPD-relasted deaths stirring in low and middle-income countries. Furthermore, the growing use of single-use flexible bronchoscopes and the strong preference of healthcare professionals for disposable bronchoscopes are additional factors propelling the expansion of this segment.
The market is divided into two categories based on End Use: Hospitals and Outpatient facilities. In 2022, outpatient facilities dominated the global market and are expected to continue experiencing substantial growth throughout the forecast period. The key driver of demand within this segment is the increasing number of outpatient facilities performing endoscopic procedures. Additionally, factors such as the easy accessibility of outpatient facilities and the cost-effectiveness of services support the expansion of this market. Furthermore, government initiatives aimed at fortifying healthcare infrastructure are anticipated to further boost the uptake of services within this segment in the coming years.
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Companies in the Disposable Endoscope Market are also adopting a range of strategies to meet the demands of the evolving healthcare landscape. These strategies include product innovation to create more cost-effective and user-friendly disposable endoscopes, regulatory compliance to ensure their products meet quality and safety standards, and expanding their product lines to cover a wider array of medical specialties and procedures. Additionally, companies are actively engaging in partnerships and collaborations with healthcare institutions to promote the adoption of disposable endoscopes. They are also focusing on educating healthcare professionals and patients about the advantages of disposable endoscopes, such as reducing the risk of infections. Overall, their strategies revolve around enhancing patient care and healthcare efficiency.
In February 2022, Ambu announced the U.S. FDA clearance of Ambu aScope Gastro and Ambu aBox 2, strengthening its presence in the GI space.
In August 2021, Boston Scientific's single-use bronchoscope received 510(k) clearance from the U.S. FDA, allowing its utilization in ICU and operating rooms. This device is exceptionally well-suited for performing numerous bronchoscopy procedures.